Call customer care on: 0333 358 0200
meds prescribed online, delivered discretely to your door

Oral contraception prescribed online, delivered discretely to your door

We will recommend a personalised treatment plan for you

Ovranette

Oral medication

Ovranette is a monophasic 21-day contraceptive pill containing the active ingredients ethinylestradiol and levonorgestrel. It helps to make it harder for the sperm to penetrate the womb and to reduce the chance of a fertilised egg implanting in the womb. It is over 99% effective at preventing pregnancy if taken correctly.

Medication effect duration

Ovranette is a prescription only medicine, like any other prescription medication you must consult a doctor before using it.

 Nutrition information for medication

PrivateDoc offers a confidential free consultation service that may result in you receiving a prescription for Ovranette if it is deemed appropriate and can prescribed safely. Complete a 100% free and secure consultation to explore your treatment options.

Who can take Ovranette

PrivateDoc will prescribe a 3-month supply of Ovranette contraceptive pill to women where Ovranette is suitable. Women qualify for Ovranette if:

  • They have been taking Ovranette for the last year.
  • They have had no problems with Ovranette in the last year.
  • They have had a face-to-face pill check-up for their contraceptive pill in the last year.

How to take Ovranette

Take Ovranette every day for 21 days

  • Ovranette comes in strips of 21 pills, each marked with a day of the week.
  • Take your pill at the same time every day.
  • Start by taking a pill marked with the correct day of the week.
  • Follow the direction of the arrows on the strip. Take one pill each day, until you have finished all 21 pills
  • Then have a 7-day break when you will have your period.
  • Following the 7-day pill-free period start your new pack of pills on the 8th day.
  • Note – Swallow each pill whole, with water if necessary.
Get Started

Treatment Warnings

Do not take Ovranette if you:

  • Breastfeeding: < 6 weeks postpartum
  • History of confirmed venous thromboembolism (VTE). Known risk factors for VTE.
  • Arterial thrombotic disorders (Cerebrovascular accident or coronary artery disease) or a history of these conditions, or prodromal conditions (e.g. angina pectoris and transient ischaemic attack)
  • Smoking in women aged > 35 years who smoke > 15 cigarettes per day
  • Severe or uncontrolled hypertension
  • Known thrombogenic mutations, thrombogenic valvulopathies or congenital heart disease
  • History of migraine with focal neurological symptoms
  • Diabetes mellitus with vascular involvement
  • Systemic Lupus Erythematosus (SLE) with positive (or unknown) antiphospholipid antibodies
  • The presence of a severe or multiple risk factor(s) for venous or arterial thrombosis may also constitute a contraindication
  • Acute or severe chronic liver diseases, current or previous, as long as liver function values have not returned to normal
  • Presence or history of liver tumours (benign or malignant)
  • Known or suspected carcinoma of the breast or other known or suspected estrogen-dependent neoplasia
  • Undiagnosed vaginal bleeding
  • Hypersensitivity to the active substances